Carrying Forward the Spirit of Lou Shan Pass and Bravely Scaling New Heights in the Industry—The BioAlly Tengger Desert Elite Challenge and the Launch Event for “Three Major New Products” Conclude Successfully
Carrying Forward the Spirit of Lou Shan Pass and Bravely Scaling New Heights in the Industry—The BioAlly Tengger Desert Elite Challenge and the Launch Event for “Three Major New Products” Conclude Successfully
2025-09-01
Summary:
2025 year 8 month 24 Date to 27 Day, Tengger Desert, Alxa Left Banner, Inner Mongolia Witnessed a fusion of courage, conviction, and innovation. a grand event —Hosted by Taizhou BioAlly Biotechnology Co., Ltd. [ Let’s start from the beginning and move forward together. ]Tengger Desert Elite Challenge and “Three Major New Product” Launch Event. This event combines a desert hiking challenge with the inheritance of the revolutionary spirit. a unique form , profoundly“ The perilous pass seems as tough as iron, yet now we stride forward and surmount it once more. ” of The Lou Shan Pass Spirit showcases BioAlly. With pets Medical care Field The unwavering commitment to deep cultivation with Continuous Innovation of With unwavering strength, it has struck a resounding note of corporate advancement across the boundless sea of sand. “ The New Long March ” Movement.

“ The Lou Shan Pass Spirit ” Inheritance: Unshakable Faith, Relentless Progress
8 month 25 On the evening of [date], BioAlly’s launch event for its “three new products” was grandly held in Alxa Left Banner, Inner Mongolia. The meeting began with a shocking video. Opening , The system reviewed BioAlly since 2018 the four significant stages of development that the organization has undergone since relocating from Beijing to China Pharmaceutical City. Along the way, BioAlly consistently upholds technological innovation and quality first. Gradually Develop into A national high-tech enterprise dedicated to the innovative research, development, manufacturing, and marketing of biopharmaceutical products, leading both in China and globally. As of now, the company New Veterinary Drug Certificate Obtained 8 Item (one of the categories) 1 One, Category II 3 1) National Invention Patent 15 Item: U.S. Utility Patent 1 item , demonstrating Excellence of R&D strength and product innovation capability.
The event featured Mao Zedong’s “Yi Qin E” ·The historical background of “Loushanguan” as an introduction , providing an in-depth interpretation of the Lou Shan Pass Spirit. “ Unafraid of hardship, courageous in breaking new ground, steadfast in conviction, and daring to achieve victory. ” the core essence. This invaluable spirit, born in the revolutionary era, provides powerful spiritual guidance for enterprises to break through development bottlenecks and achieve innovative upgrades in today’s complex economic environment. Looking ahead, as the industry presents both opportunities and challenges, the company will continue to be guided by the Lou Shan Pass Spirit, and with “ Surpass from the beginning ” with courage and determination, surmounting developmental obstacles and boldly scaling the heights of the industry, thereby continuously injecting momentum into the high-quality development of China’s pet healthcare sector. New Products and New Momentum 。


Three Arrows Fired at Once: Launch of Three Major New Products Highlights Innovative Strength
This launch event will be held with “ Breaking Boundaries, Rebirth, Peace ” Centered around three core thematic sections, the event unveiled three industry-defining new products, offering a comprehensive showcase of Company Innovative strength and strategic vision in the pet healthcare sector.
Meow Care Registered trademark : As China’s first officially registered feline trivalent vaccine, this product has not only been awarded a National Class II New Veterinary Drug Certificate but has also marked a major breakthrough in the R&D and industrialization of domestically produced pet vaccines. Chairman Wang Hongwei revealed that the product has currently secured four patents in China and the United States, with additional 3 This patent is currently undergoing substantive examination and is expected to ultimately result in a total of 7 This invention patent fully embodies BioAlly’s innovative philosophy of “using technology to break foreign monopolies” and its robust technological capabilities.
Bonison TM Prednisolone Tablets: Providing a safer, more effective option for clinical treatment in pets. Filled the gap Unmet medical needs in the field of hormonal therapy for pets. The launch of this product further enhances the company’s product portfolio in the pet pharmaceuticals sector.
MeowCare Recombinant Cat - Interferon ω: This product is developed using cutting-edge biotechnology. Can effectively Enhancing the prevention and control of feline viral diseases and tumors has significantly expanded BioAlly’s product portfolio in the areas of antiviral, antitumor, and immunomodulatory therapies for pets, particularly with the world’s first-ever “Injection” + The dual usage of “eye drops” further Show BioAlly Our corporate mission is to put the life and health of pets at the forefront and leverage technology to safeguard their well-being.
At the event site, Representatives from the distributors, Qiang Yongli and Kim Kyung-seok, also delivered speeches, They shared their firsthand experiences throughout the collaboration with BioAlly, highly commended the company’s product quality and its corporate philosophy, and expressed their appreciation for this… Publish We are highly confident in the market prospects for this new product and look forward to continuing our collaboration with BioAlly to jointly open up new frontiers in the pet healthcare market and contribute to the industry’s development.


In addition, Chairman Wang Hongwei announced a major piece of news at the conference: 20% Bioshengjian at a certain concentration Registered trademark Also soon Formal Launch to the market . The launch of this product, Will further consolidate BioAlly’s technological leadership in the pet healthcare sector. Status, enhance Company Market competitiveness injects new momentum into the industry’s development.

Spiritual Refinement: Desert Challenges and Cultural Fusion
The two-day Tengger Desert Elite Challenge is equally significant. “Tengger” means “sky god” in Mongolian, and this region Vast Sea of Sand Becoming a crucible for team spirit , testing collaborative ability a natural stage. In extreme conditions, team members hiked across endless sand dunes, Realization “The hardest part is not the sand dunes, but the perseverance within.” It resonates profoundly with the spirit of Lou Shan Pass.
At the launch event, everyone passionately recited “Yi Qin E.” ·Lou Shan Pass , impassioned verses echo across the desert night sky , bringing the entire atmosphere to a climax. Subsequently, The spectacular launch ceremony for the “Three Arrows Fired Simultaneously” unfolded, with dazzling fireworks bursting forth in the desert night sky. , symbolizing the official launch of the three new products and the beginning of a new chapter in the market. 。 As night falls, the bonfire party kicks off in full swing. , melodious throat singing, vigorous Mongolian dance, and intense wrestling performances Taking turns to appear , blending the grandeur of grassland culture with the steadfast spirit of Lou Shan Pass. Everyone gathered around the bonfire, singing and dancing, deepening their understanding and trust of one another amid laughter and joy. Vividly embodies BioAlly. The team philosophy of “Let’s go together,” Deepened A sense of belonging and cohesion among all attendees.



This Tengger Desert Elite Challenge and “ Three New Products ” The listing ceremony serves as a crucial platform for BioAlly to communicate its commitment to industry development. : In an era full of uncertainty, we More We must be guided by the spirit of Lou Shan Pass. Uphold a steadfast strategy, pursue continuous innovation, and rigorously build our team to achieve sustainable, high-quality development. Chairman Wang Hongwei stated: “In the future, BioAlly will continue to ramp up R&D investment, with sustained efforts in areas such as veterinary vaccines and therapeutic biologics, striving to become the ‘Huawei’ of the pet pharmaceutical industry!”
Other News